ANXA1 and neoplasm: In addition, it has been hypothesized that anxA1 could act to modulate the tumor immune environment, and anxA1 and its cleavage products are known to modulate neutrophil extravasation and transendothelial migration through interaction with formyl peptide receptors [52, 70, 71].